According to the latest financial report of ZEALAND PHARMA AS, the latest earnings per share (TTM) for the company is -3.77. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about ZEALAND PHARMA AS's free cash flow? The latest report shows it as -295.87M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ZEALAND PHARMA AS shows that the company's current ratio is 35.49, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ZEALAND PHARMA AS, the quick ratio is 35.27, indicating that the company can meet its short-term debt obligations.
Want to learn more about the financial health of ZEALAND PHARMA AS? The latest ROE figure is -2.91%, indicating that the company has stable profitability.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ZEALAND PHARMA AS, the total asset return on investment (ROA) is -2.69%.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check ZEALAND PHARMA AS's latest financial report to see how their gross margin is doing - currently at 249.94%.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ZEALAND PHARMA AS, the net profit margin is -6.03K%, which is a good sign for its profitability.